Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening

Sponsor
The Filatov Institute of Eye Diseases and Tissue Therapy
Study ID
NCT06879834
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Accepted

Interventions

  • taking fundus photos using non-mydriatic fundus camera — DEVICE
    using artificial intelligence to identify diabetic retinopathy in the early stages using fundus photography.

Study Details

To examine the potential for the detection of diabetic retinopathy (DR) using the artificial intelligence (AI)-based software platform Retina-AI.

Key Dates

First listed
Mar 17, 2025
Start date
Nov 2, 2024
Status verified
Mar 2025
Primary completion
Aug 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: main group
    have diabetes mellitus
  • Arm: control group
    have risk factors for developing diabetes mellitus

Primary Outcome Measure

The accuracy [ Time Frame: Baseline ]

Central Contacts

Find similar trials

Nationwide
Diabetic retinopathy trialsOphthalmology trialsRetina trials

Related Studies